Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la Facultad de Medicina
Print version ISSN 0120-0011
Abstract
MOYANO-ACEVEDO, Jairo Ricardo; RODRIGUEZ-BOLANOS, Paula Isabel and FIERRO-MARQUEZ, Cindy Lorenna. Use of systemic lidocaine for postoperative acute pain management in single-lung transplantation: Case report. rev.fac.med. [online]. 2020, vol.68, n.2, pp.321-324. Epub June 29, 2021. ISSN 0120-0011. https://doi.org/10.15446/revfacmed.v68n2.75649.
Introduction:
Lung transplantation is associated with severe pain, which can delay recovery. Systemic lidocaine has useful analgesic properties for managing acute pain; however, little is known on its use after lung transplantation. Due to pharmacological alterations during the postoperative period, the use of analgesics implies a demanding process to avoid toxicity, so lidocaine may play a role in this scenario. In this sense, the purpose of this case report is to present the use of systemic lidocaine as an option for acute pain management when other analgesics fail.
Case presentation:
The following is the case of a male patient with acute pain in the postoperative period of single-lung transplantation. Opioids and non-opioid analgesics showed limited efficacy, so systematic lidocaine was administered. Systemic administration of lidocaine was effective for pain control, functional recovery, and opioid decrease during the postoperative period.
Conclusions:
Systemic administration of lidocaine was a useful alternative for achieving optimal postoperative pain management in lung transplantation, since it allowed adequate analgesia and lung function recovery with decreased use of opioids. This drug may be a component of multimodal analgesia in selected patients when other options fail however, its routine use is not recommended.
Keywords : Acute Pain; Lung; Transplantation; Lidocaine; Metabolism (MeSH).